MMP-2 and VEGF, as transcriptional targets of HIF-1, play an important role in angiogenesis of NSCLC and GBM via the PI3K/AKT signaling pathway [42, 43]. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.